SCHEMBL2708402

SCHEMBL2708402

Nc1cccc(-c2ccn(-c3ccc(OC(F)(F)F)cc3)n2)c1

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 2/20 0.51
BCR P11274 1/20 0.51
MAPT P10636 2/20 0.45
MAPK1 P28482 2/20 0.45
KDM4E B2RXH2 1/20 0.45
GAA P10253 1/20 0.45
RECQL P46063 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
XDH P47989 1/20 0.39
SCN5A Q14524 3/20 0.39
SCN9A Q15858 1/20 0.39
PDE10A Q9Y233 1/20 0.38
DYRK1A Q13627 3/20 0.37
NPY5R Q15761 1/20 0.37
ADORA2A P29274 1/20 0.37
CYP1A2 P05177 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19121067 0.84 SCN5A (0.47) MAPTMAPK1KDM4EGAARECQL
SCHEMBL2708649 0.83 RAB9A (0.48) MAPTKDM4EADORA2A
SCHEMBL182081 0.82 MRGPRX4 (0.49) ABL1BCRMAPTMAPK1KDM4E
SCHEMBL182036 0.82 GRM5 (0.53) ABL1MAPTMAPK1KDM4EGAA
SCHEMBL17125341 0.81 DYRK1A (0.45) ABL1BCRMAPTMAPK1KDM4E
SCHEMBL2708555 0.80 ALDH1A1 (0.50) MAPTKDM4EL3MBTL1
SCHEMBL2707485 0.75 ALDH1A1 (0.50) MAPTMAPK1KDM4EADORA2A
SCHEMBL19121178 0.75 MAPT (0.42) MAPTMAPK1KDM4EGAARECQL
SCHEMBL1241524 0.75 ABL1 (0.54) ABL1BCRMAPK1SCN5A
SCHEMBL30363971 0.75 ABL1 (0.54) ABL1BCRMAPK1SCN5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2387995-A1 Methods for the production of functional protein from DNA having a nonsense mutation and the treatment of disorders associated therewith PTC Therapeutics, Inc. (US) 2011-11-23 EP disclosed
WO-2007117438-A2 METHODS FOR THE PRODUCTION OF FUNCTIONAL PROTEIN FROM DNA HAVING A NONSENSE MUTATION AND THE TREATMENT OF DISORDERS ASSOCIATED THEREWITH PTC THERAPEUTICS, INC. (US) 2007-10-18 WO disclosed